Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. (2006). Journal of Carcinogenesis, 5(1). https://carcinogenesis.com/index.php/JOC/article/view/227